![](/img/cover-not-exists.png)
PGI9 COST-EFFECTIVENESS OF TOFACITINIB COMPARED WITH INFLIXIMAB, ADALIMUMAB, GOLIMUMAB AND VEDOLIZUMAB FOR THE TREATMENT OF MODERATE TO SEVERE ULCERATIVE COLITIS IN GERMANY
Quon, P., Sardesai, A., Milev, S., DiBonaventura, M., Cappelleri, J.C., Kisser, A., Modesto, I., Dietz, L., Dignass, A., Bargo, D.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.1132
Date:
November, 2019
File:
PDF, 320 KB
2019